Integer beats The Street in Q3, plans to acquire Oscor

Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor.

The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see the acquisition broadening Integer’s product portfolio, expanding its R&D capabilities, and adding low-cost manufacturing capacity.

“We’re excited to welcome Oscor’s approximately 900 associates to Integer, who will bring a trusted brand with 40 years of medical device development and manufacturing combined with a complementary product offering and extensive intellectual property portfolio,” Integer CEO Joseph Dziedzic said in a news release.

Dziedzic suggested that Integer is in a financial position to continue shopping: “The execution of our …

Read more
  • 0

Integer plans $30 million innovation and manufacturing facility in Galway

Integer Holdings Corp. (NYSE: ITGR) plans to build a medical device innovation and manufacturing facility in the Parkmore East area of Galway, Ireland.

Plano, Texas-based Integer said the initial phase of the project will total 60,000 square feet and a $30 million investment over the coming years, with construction scheduled from 2022 to late 2023 and equipment investments continuing for another two or three years.

Integer said it has planning permission for another 87,000 square feet of expansion when needed.

The medical device outsource manufacturer cited increased demand for regional research, development and manufacturing capabilities as well as capacity for catheters and delivery systems. Integer already has an R&D center in Galway and counts the manufacturing facilities in Galway and New Ross, County Wexford, among its 15 global manufacturing sites.

The expansion is expected to add 100 to 200 new jobs in engineering, administration and m…

Read more
  • 0